Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma
- 31 March 2002
- journal article
- Published by Elsevier in American Journal Of Medicine
- Vol. 112 (4), 262-268
- https://doi.org/10.1016/s0002-9343(01)01117-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Results of the 1988–1989 patterns of care study process survey for Hodgkin’s diseaseInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Whole-body 18F-FDG PET for the evaluation of patients with Hodgkinʼs disease and non-Hodgkinʼs lymphomaNuclear Medicine Communications, 1999
- Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1998
- The continuing clinical role of gallium 67 scintigraphy in the age of receptor imagingSeminars in Nuclear Medicine, 1997
- New diagnostic imaging procedures in Hodgkin's diseaseAnnals of Oncology, 1996
- High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphomaAnnals of Oncology, 1996
- The role of high dose 67‐gallium scintigraphy in staging untreated patients with lymphomaAustralian and New Zealand Journal of Medicine, 1994
- Current role of gallium scanning in the management of lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- The Non-Hodgkin Lymphoma Pathologic Classification ProjectAnnals of Internal Medicine, 1988
- Planning mantle radiation therapy in patients with Hodgkin disease: role of gallium-67 scintigraphyAmerican Journal of Roentgenology, 1988